1. 5-Aza-2′-deoxycytidine, a DNA methylation inhibitor, induces cytotoxicity, cell cycle dynamics and alters expression of DNA methyltransferase 1 and 3A in mouse hippocampus-derived neuronal HT22 cells
   Jing Yang et al, 2017, Journal of Toxicology and Environmental Health, Part A CrossRef
2. Impact of Natural Compounds on DNA Methylation Levels of the Tumor Suppressor Gene RASSF1A in Cancer
   Reinhard Dammann et al, 2017, IJMS CrossRef
3. Different survival benefits of Chinese medicine for pancreatic cancer: How to choose?
   Meng Li et al, 2017, Chin. J. Integr. Med. CrossRef
4. Role of Emodin in Chemosensitization of Cancer
   Subash Chandra Gupta et al, 2018 CrossRef
5. Endogenous Opiates and Behavior: 2016
   Richard J. Bodnar, 2018, Peptides CrossRef
6. A novel epigenetic modulating agent sensitizes pancreatic cells to a chemotherapy agent
   Manjusha Thakar et al, 2018, PLoS ONE CrossRef
7. Aberrant methylation-induced dysfunction of p16 is associated with osteoblast activation caused by fluoride
   Shouli Wu et al, 2018, Environmental Toxicology CrossRef
8. An overview of epigenetic agents and natural nutrition products targeting DNA methyltransferase, histone deacetylases and microRNAs
   Deyu Huang et al, 2018, Food and Chemical Toxicology CrossRef
9. Emodin Rescued Hyperhomocysteinemia-Induced Dementia and Alzheimer’s Disease-Like Features in Rats
   Peng Zeng et al, 2018 CrossRef
10. The Roles of Natural Compounds in Epigenetics
    Yanhong Yang et al, 2018, Natural Product Communications CrossRef
11. RASSF1A Tumour Suppressor: Target the Network for Effective Cancer Therapy
    Lucía García-Gutiérrez et al, 2020, Cancers CrossRef
12. Dietary natural products as epigenetic modifiers in aging-associated inflammation and disease
    Levi W. Evans et al, 2020, Nat. Prod. Rep. CrossRef
13. DNMT1 as a therapeutic target in pancreatic cancer: mechanisms and clinical implications
    Kah Keng Wong, 2020, Cell Oncol. CrossRef
14. Identification of DNA methylation‑driven genes by integrative analysis of DNA methylation and transcriptome data in pancreatic adenocarcinoma
    Wei Zhang et al, 2020, Exp Ther Med CrossRef
15. EZH2 inhibition sensitizes tamoxifen‑resistant breast cancer cells through cell cycle regulation
    Si Chen et al, 2017, Mol Med Report CrossRef
16. Emodin inhibits pancreatic cancer EMT and invasion by up‑regulating microRNA‑1271.
    Nan Li et al, 2018, Mol Med Rep CrossRef
17. Chrysophanol inhibits proliferation and induces apoptosis through NF-κB/cyclin D1 and NF-κB/Bcl-2 signaling cascade in breast cancer cell lines
    Li Ren et al, 2018, Mol Med Report CrossRef
18. Associations between the expression of SCCA, MTA1, P16, Ki‑67 and the infection of high‑risk HPV in cervical lesions
    Cuina Han et al, 2020, Oncol Lett CrossRef
19. What we already know about rhubarb: a comprehensive review
    Hong Xiang et al, 2020, Chin Med CrossRef
20. Traditional Chinese medicine may be further explored as candidate drugs for pancreatic cancer: A review
    Yue Gao et al, 2020, Phytotherapy Research CrossRef
21. Integrative Management of Pancreatic Cancer (PDAC): Emerging Complementary Agents and Modalities
    Mustafa B. A. Djamgoz et al, 2021, Nutrition and Cancer CrossRef
22. Advances in the study of emodin: an update on pharmacological properties and mechanistic basis
    Qi Zheng et al, 2021, Chin Med CrossRef
23. Natural Bioactive Compounds Targeting Epigenetic Pathways in Cancer: A Review on Alkaloids, Terpenoids, Quinones, and Isothiocyanates
    Nasreddine El Omari et al, 2021, Nutrients CrossRef
24. Evidence for a novel, effective approach to targeting carcinoma catabolism exploiting the first-in-class, anti-cancer mitochondrial drug, CPI-613
    Moises O. Guardado Rivas et al, 2022, PLoS ONE CrossRef
25. The roles of DNA methylation on the promotor of the Epstein–Barr virus (EBV) gene and the genome in patients with EBV-associated diseases
    Linlin Zhang et al, 2022, Appl Microbiol Biotechnol CrossRef
26. Epigenetics and the role of nutraceuticals in health and disease
    Amr El-Sayed et al, 2023, Environ Sci Pollut Res CrossRef
27. Nephroprotective and nephrotoxic effects of Rhubarb and their molecular mechanisms
    Fang Zhang et al, 2023, Biomedicine & Pharmacotherapy CrossRef
28. Research progress of traditional Chinese medicine as sensitizer in reversing chemoresistance of colorectal cancer
    Xiang Lin et al, 2023, Front. Oncol. CrossRef
29. Recent findings regarding the synergistic effects of emodin and its analogs with other bioactive compounds: Insights into new mechanisms
    Yue Hu et al, 2023, Biomedicine & Pharmacotherapy CrossRef
30. Advances in the treatment of pancreatic cancer with traditional Chinese medicine
    Yanhua Zhang et al, 2023, Front. Pharmacol. CrossRef
31. Natural bioactive compounds targeting DNA methyltransferase enzymes in cancer: Mechanisms insights and efficiencies
    Tarik Aanniz et al, 2024, Chemico-Biological Interactions CrossRef
32. Andrographolide suppresses the malignancy of pancreatic cancer via alleviating DNMT3B-dependent repression of tumor suppressor gene ZNF382
    Kai-Ru Zhuang et al, 2024, Phytomedicine CrossRef
33. Studies on the Ameliorative Potential of Rheum Webbianum Rhizome Extracts on 1,2-Dimethylhydrazine (DMH) Induced Colorectal Cancer and Associated Hepatic and Haematological Abnormalities in Swiss Albino Rats
    Umer Majeed Khaja et al, 2024, Journal of Ethnopharmacology CrossRef
34. The application of rhubarb concoctions in traditional Chinese medicine and its compounds, processing methods, pharmacology, toxicology and clinical research
    Yi Wen et al, 2024, Front. Pharmacol. CrossRef
35. Raddeanin A Suppresses Intracellular 5Methylcytosine (5mC) DNA Modification Engaged the Metastasis of Hepatocellular Carcinoma (HCC)
    Xin Liu et al, 2024, Journal of Ethnopharmacology CrossRef
36. Lipidomics-based natural products for chronic kidney disease treatment
    Rui Zhang et al, 2025, Heliyon CrossRef